We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The origin
- Objectives
- Key considerations
- AI and its transformative impact
- Screening for trials
- Definitions
- AI in healthcare
- Why AI in healthcare? (1)
- Why AI in healthcare? (2)
- Documentation?
- Cancer diagnostics
- Imaging
- Pathology
- AI in clinical oncology research
- Electronic Medical Records (EMR)
- NGS data
- Looking for clinical trials
- AI in drug development
- AI: A cautionary perspective
- Checks and balances
- Ethical implications in medical diagnosis & treatment
- Financial disclosures
- Acknowledgements
Topics Covered
- AI terms & definitions
- History of AI and its role in healthcare
- AI and its impact in clinical development, diagnostics and clinical research
- AI in drug discovery and development
- Legal and ethical considerations in AI
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Sengupta, S. (2026, March 31). Leveraging healthcare data through artificial intelligence [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 18, 2026, from https://doi.org/10.69645/EQWA9492.Export Citation (RIS)
Publication History
- Published on March 31, 2026
Financial Disclosures
- Prof. Soma Sengupta is the Consultant for Imvax; Co-founder, AMLAL Pharmaceuticals Inc.; Member of the Drug Safety Monitoring Board, Bexion Pharmaceuticals, Inc.; External adviser to Novocure and Jupiter Bioventures Inc.
Other Talks in the Series: Periodic Reports: Advances in Clinical Interventions and Research Platforms
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. I'm Soma Sengupta.
Today, I'm going to
talk about leveraging
healthcare data through
artificial intelligence.
This is part of the Biomedical
and Life Sciences
collection for HSTalks.
0:16
I would like to propose
to consider the question,
"Can machines think?"
That's a quote from Alan Turing.
Why Alan Turing?
Because he is commonly thought
of as the father of AI.
0:33
The objectives are as follows:
Understand the common AI
(artificial intelligence)
terms and definitions.
Understand the history of AI
and its role in oncology.
Examine AI's impact on
clinical development
and diagnosis.
Explore AI applications in
drug discovery and development.
Explore AI's impact
on clinical research.
Consider where AI is headed
and general concerns.
1:02
The things we need
to think about are
that we need to ensure
that there's data privacy,
there's an ethical use of AI,
how one can integrate AI
into clinical workflows,
and that there is
regulatory compliance.
1:20
If we think of AI and its
transformative impact,
there's accelerating, which is
drug discovery and development,
enhancing clinical development,
improving cancer diagnostics,
addressing regulatory
and healthcare
professional challenges,
streamlining workflows
and reducing costs.
AI can be used to help in
cancer predictions, screening,
patient input, cancer diagnosis,
therapy guidance, and response
assessment to treatment.
This can also guide
the clinician
and also dictate how
surveillance could occur.